Usher syndrome: clinical features, molecular genetics and advancing therapeutics

M Toms, W Pagarkar… - Therapeutic advances in …, 2020 - journals.sagepub.com
Usher syndrome has three subtypes, each being clinically and genetically heterogeneous
characterised by sensorineural hearing loss and retinitis pigmentosa (RP), with or without …

[HTML][HTML] USH2A-retinopathy: From genetics to therapeutics

L Toualbi, M Toms, M Moosajee - Experimental Eye Research, 2020 - Elsevier
Bilallelic variants in the USH2A gene can cause Usher syndrome type 2 and non-syndromic
retinitis pigmentosa. In both disorders, the retinal phenotype involves progressive rod …

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations

K Dulla, R Slijkerman, HC van Diepen, S Albert… - Molecular Therapy, 2021 - cell.com
Mutations in USH2A are among the most common causes of syndromic and non-syndromic
retinitis pigmentosa (RP). The two most recurrent mutations in USH2A, c. 2299delG and c …

[HTML][HTML] Molecular epidemiology in 591 Italian probands with nonsyndromic retinitis pigmentosa and usher syndrome

L Colombo, PE Maltese, M Castori… - … & Visual Science, 2021 - tvst.arvojournals.org
Purpose: To describe the molecular epidemiology of nonsyndromic retinitis pigmentosa (RP)
and Usher syndrome (US) in Italian patients. Methods: A total of 591 probands (315 with …

Usherin defects lead to early-onset retinal dysfunction in zebrafish

M Dona, R Slijkerman, K Lerner, S Broekman… - Experimental eye …, 2018 - Elsevier
Mutations in USH2A are the most frequent cause of Usher syndrome and autosomal
recessive nonsyndromic retinitis pigmentosa. To unravel the pathogenic mechanisms …

Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2

M Stemerdink, B García-Bohórquez, R Schellens… - Human Genetics, 2021 - Springer
Usher syndrome (USH) is a rare, autosomal recessively inherited disorder resulting in a
combination of sensorineural hearing loss and a progressive loss of vision resulting from …

RNA therapeutics in ophthalmology-translation to clinical trials

A Gupta, KN Kafetzis, AD Tagalakis… - Experimental eye …, 2021 - Elsevier
The use of RNA interference technology has proven to inhibit the expression of many target
genes involved in the underlying pathogenesis of several diseases affecting various …

CDHR1 mutations in retinal dystrophies

K Stingl, AK Mayer, P Llavona, L Mulahasanovic… - Scientific reports, 2017 - nature.com
We report ophthalmic and genetic findings in patients with autosomal recessive retinitis
pigmentosa (RP), cone-rod dystrophy (CRD) or cone dystrophy (CD) harboring potential …

Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies

P Panikker, S Roy, A Ghosh, B Poornachandra… - Frontiers in …, 2022 - frontiersin.org
Successful sequencing of the human genome and evolving functional knowledge of gene
products has taken genomic medicine to the forefront, soon combining broadly with …

The usherin mutation c. 2299delG leads to its mislocalization and disrupts interactions with whirlin and VLGR1

L Tebbe, ML Mwoyosvi, R Crane, MS Makia… - Nature …, 2023 - nature.com
Usher syndrome (USH) is the leading cause of combined deafness-blindness with type 2 A
(USH2A) being the most common form. Knockout models of USH proteins, like the Ush2a …